GlaxoSmithKline announces sale of shares in Quest Diagnostics Inc.

Biotech NRx to sell new shares to fund growth and operations

A Veracyte Insider Sold 24,000 Company Shares for $1.1 Million. Here's a Deeper Look at the Transaction.

GSK acquires cancer drug developer Nuvalent in $10.6 billion deal

GSK has announced a $10.6 billion acquisition of Nuvalent, a biotech company developing small-molecule kinase inhibitors for treatment-resis

Xeris Biopharma Holdings, Inc. Files Form 8-K with SEC (June 29, 2026)

This is a Form 8-K filing with the SEC by Xeris Biopharma Holdings, Inc., dated June 29, 2026. The document is a regulatory filing reporting

GSK in talks to buy cancer biotech Nuvalent for more than $9bn

LiqTech International prices 20M-share public offering at $1.00/share

LiqTech International has priced a public offering of 20 million shares at $1.00 per share, expecting approximately $20 million in gross pro